SAB-139

N/A

Report date: 2024/11/14 13:52:29

Base Information

Drug NameSAB-139
Drug Alias NameSAB-139
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Polyclonal antibodies
Mechanisms of ActionAnti-EBOV
TargetsEBOV
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSab Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSab Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fever, Ebola
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A